Detalhe da pesquisa
1.
Trauma and sporadic desmoid tumor development: An approach toward real incidence and aspects of causality.
Cancer
; 130(1): 51-59, 2024 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37751183
2.
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa).
Eur J Cancer Care (Engl)
; 30(6): e13484, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34342924
3.
Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years.
Oncol Res Treat
; 43(11): 613-619, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32854101
4.
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'.
Eur J Cancer
; 134: 62-74, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32470848
5.
Clinical Presentation of Gastrointestinal Stromal Tumors.
Visc Med
; 34(5): 335-340, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-30498699
6.
Preserving quality of life as a key treatment goal in advanced soft tissue sarcomas.
Expert Rev Anticancer Ther
; 18(12): 1241-1248, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30220224
7.
Primary and secondary angiosarcomas: a comparative single-center analysis.
Clin Sarcoma Res
; 5: 14, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26413264